Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.04 – $0.12
4% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M | $3.0M | $3.5M | $3.1M | $3.2M | $3.7M | $2.8M | $3.2M |
| Cost of revenue | $1.9M | $1.5M | $1.9M | $1.9M | $2.0M | $2.0M | $1.8M | $1.8M |
| Gross profit | $1.9M | $1.6M | $1.6M | $1.2M | $1.2M | $1.7M | $1.1M | $1.4M |
| Gross margin | 50.3% | 51.8% | 45.2% | 37.6% | 38.9% | 45.1% | 38.5% | 43.7% |
| R&D | $527.7K | $673.9K | $589.4K | $656.0K | $615.9K | $541.2K | $581.1K | $517.3K |
| Operating income | −$66.2K | −$374.7K | −$17.8K | −$670.5K | −$1.1M | $43.4K | −$601.5K | −$94.0K |
| EBITDA | −$9.3K | −$308.7K | $21.7K | −$506.4K | −$1.0M | $80.4K | −$514.0K | $12.3K |
| Net income | $109.7K | −$342.6K | −$95.8K | −$598.3K | −$1.4M | −$96.3K | −$716.9K | −$123.1K |
| Net margin | 2.9% | -11.3% | -2.7% | -19.4% | -43.2% | -2.6% | -25.2% | -3.8% |
| EPS (diluted) | 0.00 | -0.01 | -0.00 | -0.01 | -0.02 | -0.00 | -0.01 | -0.00 |
Annual figures · source: Financial Modeling Prep
ADM TRONICS UNLTD INC
No one on the platform currently holds ADMT.
No tracked institution reports a position in ADMT as of their last filing.
No one on the platform has traded ADMT yet.
| $2M |
| — |
| GBCSSelectis Health, Inc. | $5.21 | -0.38% | $16M | — |
| HEWAHealthWarehouse.com, Inc. | $0.13 | +0.00% | $6M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ZOMDF I've been following both companies for years looks like they are both advancing well. $ADMT
View on StockTwits ↗$ADMT Awarded U.S. Patent for Novel Non-Invasive Musculoskeletal Pain Therapy Technology Technology Powers Sonotron® Medical Device Advancing Toward FDA Submission May 19, 2026 - ADMT, a diversified technology development and manufacturing company specializing in advanced therapeutic medical technologies, today announced that the United States Patent and Trademark Office (“USPTO”) awarded the Company a patent covering its innovative non-invasive musculoskeletal pain treatment technology. The newly issued patent protects ADM Tronics’ proprietary therapeutic platform developed over several years of intensive research, engineering, and clinical advancement. The patented technology forms the foundation of the Company’s Sonotron®, medical device being finalized for submission to the U.S. Food and Drug Administration (“FDA”) for clearance to market for treatment of human musculoskeletal pain ...
View on StockTwits ↗$ADMT The Vet Sonotron made it to the final 4! You can vote once per day, per device until April 20 at manufacturingcounts.org
View on StockTwits ↗$ADMT The Vet Sonotron has made it to the third round of voting for the Coolest Thing Made in New Jersey. It made it to the final 8! You can vote on manufacturingcounts.org.
View on StockTwits ↗$ADMT someone bought a big chunk today. I wonder if something’s brewing.
View on StockTwits ↗Fundamental analysis of $ADMT (ADM TRONICS UNLIMITED, INC.) based on financial data and reported results. #ADMT
View on StockTwits ↗$ADMT Great piece that accurately captures ADMT's current position. So if you want to refresh your understanding of ADMT or learn about ADMT for the first time, this is essential reading. https://everyticker.com/quote/ADMT/analysis/admt-s-niche-moats-meet-going-concern-reality-a-micro-cap-medical-manufacturer-at-the-crossroads-otc-admt
View on StockTwits ↗$ADMT Hex CSTI u finished selling? Waiting with my BID at 0.075 😎
View on StockTwits ↗$ADMT probably just one investor unloading all their shares. Maybe needs the cash for the holidays.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 0.9× sales vs its 1.9× historical median P/S.
Fair value ≈ $0.08 · price $0.04 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.